Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer (Q35102667)

6 August 2017

Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer (English)

1 reference

6 August 2017

1 reference

5

Louise A Brinton

1 reference

6 August 2017

3

Ruth M Pfeiffer

1 reference

6 August 2017

1

Sarah J Nyante

1 reference

6 August 2017

7

Robert N Hoover

1 reference

6 August 2017

Mark E Sherman

2

1 reference

6 August 2017

Amy Berrington de Gonzalez

4

1 reference

6 August 2017

Erin J Aiello Bowles

6

1 reference

6 August 2017

Andrew Glass

8

1 reference

6 August 2017

Gretchen L Gierach

9

1 reference

6 August 2017

language of work or name

English

0 references

publication date

6 February 2015

1 reference

Journal of the National Cancer Institute

6 August 2017

1 reference

6 August 2017

107

1 reference

6 August 2017

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

6 August 2017

1 reference

Mammographic density-a review on the current understanding of its association with breast cancer

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

Concordance between CYP2D6 genotypes obtained from tumor-derived and germline DNA.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

Interactions between tamoxifen and antidepressants via cytochrome P450 2D6.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

Tamoxifen and mammographic breast densities

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

Tamoxifen in women with breast cancer and mammographic density

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

Tamoxifen decreases extracellular TGF-beta1 secreted from breast cancer cells--a post-translational regulation involving matrix metalloproteinase activity

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

The quantitative analysis of mammographic densities.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

Tamoxifen and breast density in women at increased risk of breast cancer

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

Postmenopausal hormone therapy and change in mammographic density

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

A longitudinal study of the effects of menopause on mammographic features

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

Can tamoxifen cause a significant mammographic density change in breast parenchyma?

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

Effect of tamoxifen on mammographic density.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334825

Tamoxifen-Induced Reduction in Mammographic Density and Breast Cancer Risk Reduction: A Nested Case-Control Study

27 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU425

Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen

21 January 2018

1 reference

12 December 2020

Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy

1 reference

12 December 2020

Can mammographic densities predict effects of tamoxifen on the breast?

1 reference

12 December 2020

Significance of follow-up mammography in estimating the effect of tamoxifen in breast cancer patients who have undergone surgery

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJU425

1 reference

6 August 2017

1 reference

6 August 2017

1 reference